Antimicrobial activity of butyrate glycerides toward Salmonella Typhimurium and Clostridium perfringens.

The antimicrobial activities of n-butyric acid and its derivatives against Salmonella Typhimurium and Clostridium perfringens were studied. n-Butyric acid and its derivatives (monobutyrin and a mixture of mono-, di-, and tri-glycerides of butyric acid) were added at different concentrations (ranging from 250 to 7,000 mg/kg to a media inoculated with either Salmonella Typhimurium or C. perfringens. The antimicrobial activity of butyric acid against C. perfringens was measured at 2 bacterium concentrations and 2 inoculations involving ambient aerobic or anaerobic conditions. The most effective antimicrobial activity for Salmonella Typhimurium was observed with n-butyric acid, with 90% inhibition rate at a concentration of 1,500 mg/kg. Although minimal inhibition for Salmonella Typhimurium was observed with butyric acid glycerides, lipase addition to a mixture of mono-, di-, and triglycerides of butyric acid increased (P < 0.01) antimicrobial activity of these derivatives. Antimicrobial activity of butyric acid and its derivative against C. perfringens was higher when using a moderate initial inoculation concentration (10(5)) compared with a higher initial concentration (10(7)) of this bacterium. At a lower inoculation of C. perfringens (10(5)), >90% inhibition rate by all butyric acid glycerides was observed with prior aerobic inoculation at 2,000 mg/kg, whereas using anaerobic inoculation, only 50% monobutyrin maintained >90% inhibitory effect at 3,000 mg/kg. The antimicrobial effect of monobutyrin against C. perfringens was generally higher (P < 0.01) for 50% monobutyrin than for 100% monobutyrin. Either a mixture of butyric acid derivatives or 50% monobutyrin decreased (P < 0.01) C. perfringens in a media containing intestinal contents whereas only 50% monobutyrin decreased (P < 0.01) Salmonella Typhimurium within a media containing cecal contents from mature Leghorns. These results show that n-butyric acid and 50% monobutyrin could be used to control Salmonella Typhimurium or C. perfringens in poultry species.

Comparison of selenium levels and sources and dietary fat quality in diets for broiler breeders and layer hens.

Two experiments were carried out with broiler breeders (experiment 1) and laying hens (experiment 2) to study the effects of Se sources, in interaction with dietary level of Se or dietary fats on performance, Se incorporation into tissues (blood, liver, breast muscle, and egg) and eggs, hatchability, and glutathione peroxidase (GPX) activities in tissues and blood. Both experiments involved a 3 x 2 factorial arrangement of 3 Se sources (selenite, Se yeast, or B-Traxim Se) and either 2 levels of each source (0.1 or 0.3 mg/kg) or 2 fats (fresh or oxidized). Egg production was not affected by Se source or dietary fat in both experiments. Egg production was greater (P < 0.01) in breeder hens fed 0.3 mg/kg of Se in experiment 1. Hatchability of eggs from hens fed 0.1 mg/kg of Se was lower (P < 0.05) in hens fed Se yeast, whereas from hens fed 0.3 mg/kg of Se, it was comparable across treatments. Selenium in egg, liver, and breast muscle was greater (P < 0.01 or <0.05) in hens fed the greater concentration of Se. Eggs from breeder hens fed organic Se sources had greater (P < 0.01) Se content than those of inorganic source. Egg albumen from breeder fed Se yeast had the greatest Se (P < 0.01), whereas egg yolk from hens fed B-Traxim Se had the greatest Se (P < 0.05). These parameters were affected by interaction between dietary Se level and source (P < 0.01 or < 0.05). Selenium contents in liver and breast muscle were greater (P < 0.01) in hens fed Se yeast compared with hens fed other sources of Se. In experiment 1, liver GPX was greater (P < 0.01) in hens fed selenite or Se yeast, whereas plasma GPX was greater (P < 0.01) in hens fed selenite compared with B-Traxim Se or Se yeast. Supplementation with oxidized fat increased (P < 0.05) GPX in blood and liver. B-Traxim Se decreased (P < 0.05) malondialdehyde content in breast muscle of layers. It is concluded that broiler breeders require supplementation of 0.3 mg/kg of Se, and that there are numerous measurable advantages in using organic rather than inorganic sources for both breeders and layers.

Effect of butyric acid on the performance and carcass yield of broiler chickens.

Short-chain fatty acids such as butyrate are considered potential alternatives to antibiotic growth promoters. The efficacy of butyric acid on performance and carcass characteristics of broiler chickens was tested in two studies. The effect of dietary butyrate on the ability to withstand coccidial oocyte challenge also was investigated. In experiment 1, male broiler chickens were fed diets supplemented with 0 or 11 ppm virginiamycin or 0.2 or 0.4% butyric acid (as mono-, di-, and triglyceride). In experiment 2, broilers were fed bacitracin methylene disalicylate or 0.1 or 0.2% butyric acid. In another trial, birds vaccinated against coccidiosis were challenged with oocytes at 21 d and examined 6 d later. In experiment 1, diet treatments had no effect on body weight gain. Feed intake of the birds fed 0.4% butyric acid was decreased (P < 0.01) compared with birds fed the nonmedicated diet during the starter period, whereas birds fed 0.2% butyric acid had similar feed intake to the control birds. In experiment 2, diet treatments did not affect the performance of broiler chicks while carcass weight and breast meat yield increased (P < 0.01) in birds fed 0.2% butyric acid. With oocyte challenge, birds that had received butyric acid before challenge showed higher growth rate following the challenge compared with birds that received nonmedicated feed. Bacitracin decreased (P < 0.05%) duodenal villi crypt depth, whereas villus length was similar in birds fed butyric acid or the nonmedicated control diet. These results show that 0.2% butyric acid can help to maintain the performance and carcass quality of broilers, especially in vaccinated birds challenged with coccidiosis.

Effects of phytase supplementation on the performance, egg quality, and phosphorous excretion of laying hens fed different levels of dietary calcium and nonphytate phosphorous.

An experiment employing a factorial arrangement of two levels (3.0 and 4.0%) of Ca, two levels (0.15 and 0.25%) of nonphytate phosphorus (NPP), and two levels (0 and 300 U/kg diet) of microbial phytase was carried out with 960 ISA-brown layers from 21 to 41 wk of age. There was a significant interaction between NPP level and phytase for egg production. High NPP level and phytase supplementation increased egg production only in the second 10-wk period (31 to 41 wk). High NPP and low Ca increased feed intake, and a significant interaction between levels of NPP and Ca was observed in the first 10 wk. High NPP improved feed efficiency only in the second 10-wk period. Low NPP improved egg specific gravity and eggshell thickness but decreased Haugh units in the first 10-wk period; high NPP decreased the percentage of broken and soft-shell eggs in the second period. Low Ca decreased egg specific gravity, eggshell strength, and eggshell thickness in both periods and increased Haugh units in the second 10-wk period. Phytase supplementation decreased the percentage of broken and soft-shell eggs. High NPP increased fiber availability but decreased Ca availability. High Ca decreased Ca availability, whereas phytase increased availability of dry matter, fiber, and P. High NPP increased retention of P and Fe but also increased excretion of P. High Ca decreased retention of Zn and Fe. Phytase supplementation increased P retention, resulting in decrease of P excretion. In conclusion, supplementation of microbial phytase at a level of 300 U per kg diet of laying hens can improve egg production, decrease broken and soft egg production rate, and P excretion. The effects of phytase supplementation are significantly modified by the level of Ca and NPP.

Effect of phytase enzyme on dietary nitrogen-corrected apparent metabolizable energy and the ileal digestibility of nitrogen and amino acids in broiler chicks.

The effect of phytase on the performance, AMEn, and the ileal digestibility of N and amino acids was investigated in a 15-d trial using day-old male broilers with diets that were low in Ca (0.9% for control and 0.79% for phytase treatment) and available P (AP; 0.45% for control and 0.35% for phytase treatment). The assayed dietary phytase activity of crumble diet was 1,149 phytase unit (FTU)/kg. Chromic oxide was added to the diets to estimate ileal digestibility of N and amino acid. Excreta were collected from Day 12 to 15 to estimate AMEn. Weight gain, feed intake, and feed:gain of chicks fed phytase using diets with low Ca and AP were comparable with those observed for chicks fed more normal levels of Ca and AP. The diet with supplemental phytase had a higher AMEn (P< or =0.01) compared with the control diet. Chicks fed phytase had higher digestibilities for Val, Ile, nonessential amino acids (P< or =0.05), and total amino acids (P< or =0.01).

Characteristics of tumor cell bioactivity in oncogenic osteomalacia.

Oncogenic osteomalacia is a condition where renal phosphate wasting occurs causing defective mineralisation, in the presence of a tumor. Cultures of cells were established from a hemangiopericytoma resected from a patient with oncogenic osteomalacia. Conditioned media from the cells inhibited phosphate uptake in opossum kidney cells and stimulated of cAMP in rat osteosarcoma cells, a standard parathyroid hormone (PTH)-like assay. This cAMP stimulation was suppressed by the PTH analogue, 3-34 bPTH and also by heat and trypsin treatment of the media. Tests of conditioned media for PTH and parathyroid hormone related protein (PTHrP) immunoreactivity were negative, however, and no hybridisation to probes for PTH, PTHrP or human stanniocalcin was detected in tumor cell RNA on Northern blot. These data support the hypothesis that tumors responsible for oncogenic osteomalacia produce a humoral substance that reduces renal phosphate reabsorption and provide evidence that the factor may act via PTH/PTHrP receptors.